Introduction
============

Coronary artery disease is a defect with a narrowing of the coronary arteries that supply blood and oxygen to the heart ([@b1-etm-0-0-3003]). Off-pump coronary artery bypass (OPCAB) surgery, in which veins or arteries are grafted to the coronary arteries to bypass atherosclerotic narrowing and improve the blood supply to the heart muscle, reduces the risk of mortality from coronary artery disease ([@b2-etm-0-0-3003]). However, coronary patients who have undergone OPCAB grafting often suffer from disorders of coagulation and hemostasis ([@b3-etm-0-0-3003]). Therefore, it is necessary to research the molecular mechanisms underlying the effect of OPCAB.

Expression profile analyses have been used to examine the myocardial stress response to cardiac surgery ([@b4-etm-0-0-3003]--[@b6-etm-0-0-3003]). In addition, molecular biology studies have confirmed that several genes, including interleukin 6 (IL6), IL8 and activating transcription factor 3 (ATF3), and certain biological processes are associated with the effect of OPCAB grafting. IL6 and IL8 proteins, released by ischemic cardiac myocytes, are induced following acute ischemia ([@b5-etm-0-0-3003],[@b7-etm-0-0-3003]). Moreover, Tomic *et al* found that the expression of IL6 tended to increase after OPCAB grafting ([@b8-etm-0-0-3003]), and Ghorbel *et al* showed that ventricular heart cells may undergo alterations in chemokine and plasma cytokine levels following OPCAB surgery ([@b9-etm-0-0-3003]). Furthermore, several important miRNA regulatory relationships in OPCAB samples have been investigated. For example, microRNA (MIR)-494 targets the 3′ untranslated region of ATF3 reporter and decreases ATF3 mRNA expression ([@b10-etm-0-0-3003],[@b11-etm-0-0-3003]).

The identification of sensitive genes and miRNAs has become the focus for establishing suitable therapeutic strategies, and gene expression profiling techniques have been widely used to analyze the effects of OPCAB. A number of studies have reported some specific gene expression changes in samples following OPCAB surgery ([@b9-etm-0-0-3003],[@b12-etm-0-0-3003],[@b13-etm-0-0-3003]), while a variety of genes have been studied in the fundamental research of OPCAB. Studies have screened for genes associated with the levels of chemokines and cytokine following OPCAB surgery, but little attention has been paid to the corresponding miRNA transcripts ([@b8-etm-0-0-3003]). In addition, the molecular mechanisms of complications, including hemostasis and coagulation disorders, caused by OPCAB grafting are unclear ([@b14-etm-0-0-3003]).

In the present study, the data in the gene expression series record GSE12486 were downloaded, to screen for differentially expressed genes (DEGs) between samples obtained pre- and post-OPCAB surgery, followed by function and pathway enrichment analysis, as well as protein-protein interaction (PPI) network construction. Based on expression profiles obtained by microarray analysis, Gene Set Enrichment Analysis (GSEA) was used to enrich the miRNAs predicted to have a correlation with OPCAB grafting. Finally, miRNA regulatory networks were constructed to investigate the association between miRNA and DEGs.

Materials and methods
=====================

### Microarray data

The gene expression profile GSE12486 was obtained from the Gene Expression Omnibus database (GEO; <http://www.ncbi.nlm.nih.gov/geo/>) ([@b9-etm-0-0-3003]). The platform was GPL570 Affymetrix Human Genome U133 Plus 2.0 Array (Affymetrix, Inc., Santa Clara, CA, USA). A total of 10 myocardial samples obtained prior to and after grafting were available; they were collected from 5 patients undergoing OPCAB grafting with cardiopulmonary bypass and cardiac arrest. The pre-surgery samples contained GSM313629, GSM313631, GSM313633, GSM313635 and GSM313637, while post-surgery samples included GSM313638, GSM313639, GSM313640, GSM313641 and GSM313642.

### Data preprocessing and DEG screening

The original data were read by the Affymetrix package with R-based software and processed by the Robust Multi-array Analysis (RMA) method ([@b15-etm-0-0-3003]). The processed data then underwent normalization with a universal background in order to evaluate the expression values. The limma multiple linear regression package ([@b16-etm-0-0-3003]) was applied for the calculation and analysis of DEGs, with further rectification by the Bayes method ([@b17-etm-0-0-3003]). The genes with P\<0.01 and \|log (fold change)\|\>1 were selected as DEGs.

### Principal component analysis (PCA)

The PCA was conducted on the basis of the expression profile of DEGs. PCA is a multivariate statistical analysis that uses linear transformation to convert multiple correlated variables into a set of important linearly uncorrelated variables ([@b18-etm-0-0-3003]).

### Pathway enrichment analysis

Database for Annotation, Visualization and Integrated Discovery (DAVID) is a web-based tool for extracting the biological meaning of large numbers of genes ([@b19-etm-0-0-3003]). It was used to carry out Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of upregulated DEGs. Based on the principle of hypergeometric distribution, GO and KEGG terms were enriched with the threshold of P\<0.01.

### Protein-protein interaction (PPI) network construction

A PPI network of DEGs was constructed using the Search Tool for Retrieval of Interacting Genes (STRING) database, which provides integrated knowledge of the known and predicted associations for protein networks ([@b20-etm-0-0-3003]). The PPI network comprised 'nodes' and 'edges'; each protein was represented by a node, while the interaction of pairwise proteins was shown by an edge. The 5 nodes with the greatest number of connections (high degree) were further screened as the 'hub' genes.

### miRNA prediction analysis

GSEA is a method for the enrichment analysis of a gene set based on whole genome expression profiling ([@b21-etm-0-0-3003]). On the basis of the expression profiles obtained by microarray analysis, GSEA was used to enrich the disease-related miRNAs. The related miRNAs were screened with a threshold of false discovery rate (FDR) of \<0.05.

### miRNA regulatory networks

Cytoscape is an open software platform used for visualizing complex networks and integrating these networks with any type of attribute data ([@b22-etm-0-0-3003]). It was applied for building the regulatory networks of DEGs that were regulated by miRNA.

Results
=======

### Data standardization and DEG screening

After processing by the RMA method, the expression data presented good standardization in the samples taken pre- and post-surgery ([Fig. 1](#f1-etm-0-0-3003){ref-type="fig"}). On the basis of the differential expression analysis for GSE12486, a total of 64 DEGs with \|log2FC\| \>1 and P\<0.01 were obtained, including 63 upregulated genes and 1 downregulated gene. Perilipin 1 (PLIN1) was the only downregulated gene. The top 10 DEGs are presented in [Table I](#tI-etm-0-0-3003){ref-type="table"}.

### PCA

The DEGs were processed by the PCA method. GSM313629 and GSM313640 samples were the first principal components pre- and post grafting, respectively. As shown in [Fig. 2](#f2-etm-0-0-3003){ref-type="fig"}, the first two principal components (score, 84.88%) were well able to distinguish between the samples taken pre- and post-surgery.

### GO and KEGG pathway enrichment analysis

GO enrichment analysis of upregulated and downregulated DEGs was performed using the DAVID tool. In total, 20 GO terms were found to be enriched by the upregulated DEGs ([Table II](#tII-etm-0-0-3003){ref-type="table"}), of which several important functions were associated with immune function, such as inflammatory response, defense response, response to wounding and chemokine receptor binding. IL6, IL8, chemokine (C-C motif) ligand 4 (CCL4), CCL3, CCL2, chemokine (C-X-C motif) ligand 2 (CXCL2) and nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, ζ (NFKBIZ) were among the DEGs enriched in these significant functions.

The DAVID tool was also used for KEGG pathway analysis of the screened upregulated DEGs. Only 5 pathways were enriched ([Table III](#tIII-etm-0-0-3003){ref-type="table"}), including the chemokine signaling pathway (P=2.23E-05), cytokine-cytokine receptor interaction (P=2.24E-05), Toll-like receptor signaling pathway (P=1.08E-04), NOD-like receptor signaling pathway (P=2.09E-04) and mitogen-activated protein kinase (MAPK) signaling pathway (P=0.008586). The most significant pathway was the chemokine signaling pathway, which was enriched by the following upregulated DEGs: CCL3, CCL2, IL8, CXCR4, CCL3L1, CXCL2, CCL3L3, CCL8 and CCL4.

### PPI network construction

The PPI network, which contained 55 nodes and 234 edges, was constructed on the basis of the STRING database analysis ([Fig. 3](#f3-etm-0-0-3003){ref-type="fig"}). Based on the degree (connectivity) of the nodes, the top 10 upregulated hub nodes with higher degrees were screened. These hub genes included FBJ murine osteosarcoma viral oncogene homolog (FOS), jun proto-oncogene (JUN), ATF3, IL6, FBJ murine osteosarcoma viral oncogene homolog B (FOSB), jun B proto-oncogene (JUNB), prostaglandin-endoperoxide synthase 2 (PTGS2), early growth response 1 (EGR1), early growth response 2 (EGR2) and nuclear receptor subfamily 4, group A, member 2 (NR4A2). Among these, FOS showed the highest node degree, which was 33 ([Table IV](#tIV-etm-0-0-3003){ref-type="table"}).

### miRNA prediction analysis

In total, 36 miRNAs (FDR\<0.05) were screened by GSEA enrichment analysis ([Table V](#tV-etm-0-0-3003){ref-type="table"}). MIR-224, which was the most significant miRNA with an FDR of 0.013101, regulated 152 target genes and had a GTGACTT target site. MIR-7 was also screened as a significant miRNA (FDR, 0.13673); it regulated 163 target genes and had a GTCTTCC target site. Moreover, CAG GTCC was the target site of MIR-492 (FDR, 0.15391), which regulated 59 target genes. There were also several miRNAs that showed combined actions on one target site, such as MIR-34A, MIR-34C and MIR-449 (FDR, 0.017363), all of which acted on CACTGCC target sites and regulated a total of 273 target genes.

### miRNA regulatory network

An miRNA regulatory network was constructed from the screened miRNAs and the DEGs that they regulated. There were 176 edges and 97 nodes in the network, and the nodes consisted of 29 DEGs and 68 miRNAs ([Fig. 4](#f4-etm-0-0-3003){ref-type="fig"}). All of the DEGs were regulated by one or several miRNAs. For instance, EGR2 was regulated by 8 miRNAs, namely MIR-150, MIR-142-3P, MIR-367, MIR-363, MIR-32, MIR-92, MIR-25 and MIR-224, whereas ATF3 was only regulated by MIR-494. Similarly, each miRNA regulated one or more DEGs. MIR-142-5P regulated 6 DEGs simultaneously, namely CD69 molecule (CD69), ZFP36 ring finger protein (ZFP36), ADAM metallopeptidase with thrombospondin type 1 motif 1 (ADAMTS1), FOS, stanniocalcin 1 and early growth response 3 (EGR3), whereas MIR-194 only had a regulatory effect on solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3).

Discussion
==========

OPCAB is a type of surgery that improves blood flow to heart. In this study, GSE12486 was downloaded from the GEO to investigate the effect of this surgery on myocardial tissue on the basis of molecular mechanisms. A total of 64 DEGs, including 63 upregulated and 1 downregulated DEGs were screened. PLIN1 was the unique downregulated DEG in this study, which has been confirmed to be associated with anterolateral myocardial infarction through various metabolic pathways and axon guidance ([@b23-etm-0-0-3003],[@b24-etm-0-0-3003]).

In addition, the present study also identified that the DEGs were mainly enriched in GO terms associated with chemokine activity, transcription factor activity and transcription regulator activity, and several KEGG pathways, such as chemokine signaling pathway, cytokine-cytokine receptor interaction, and Toll-like receptor signaling pathway. The FOS gene was enriched in various GO terms such as inflammatory response, defense response and transcription regulator activity. Wu *et al* have shown that FOS is an important target of immune inflammation responses in dendritic cells ([@b25-etm-0-0-3003]). The OPCAB surgery has been confirmed to activate an inflammatory response, specific hemostatic responses and immune mechanisms ([@b26-etm-0-0-3003]). Thus, the FOS gene may be involved in the changes that occur following OPCAB grafting via an immune mechanism. In addition, FOS, IL6 and JUN were the enriched genes in the Toll-like receptor and MAPK signaling pathways. The MAPK signaling pathway can be regulated by the activation of extracellular signal-regulated kinase (ERK)1 and 2, which can translocate to the nucleus and activate transcription factors, such as c-FOS ([@b27-etm-0-0-3003]). Inhibition of the activation of MAPK may attenuate warm ischemia-reperfusion injury ([@b28-etm-0-0-3003]), and MAPK inhibition is widely used to improve cardiac function after rewarming, cold storage and reperfusion ([@b29-etm-0-0-3003]). IL6 is an independent predictor for left ventricular systolic function in patients following OPCAB surgery ([@b30-etm-0-0-3003]). Furthermore, the ratio IL10/IL6 can be used as an inflammatory biomarker in OPCAB patients ([@b31-etm-0-0-3003]). In the present study, IL6 and IL8 were enriched in inflammation-related terms, such as chemotaxis, inflammatory response, defense response and response to wounding.

Moreover, a PPI network was constructed, and 10 hub nodes including FOS, JUN, ATF3, IL6, FOSB and JUNB were screened. Among them, FOS and JUN were the most important nodes with degrees of 33 and 25, respectively. A previous study has shown a direct association of signal transducer and activator of transcription 3 with c-FOS and c-JUN in response to IL6 ([@b32-etm-0-0-3003]). The Fos family, including c-FOS, FOSB and FOSB2, are able to form dimers with JUN proteins to regulate target genes ([@b29-etm-0-0-3003]). Furthermore, ATF3 has been confirmed to inhibit IL6 transcription by altering the structure of chromatin, and then restrict access to transcription factors ([@b33-etm-0-0-3003]). In the present study, FOS, JUN, IL6 and ATF3 were also screened and enriched in transcription factor activity. A correlation between FOS and EGR2 was also shown. EGR2, which is a human zinc finger-encoding gene, is induced with c-Fos-like kinetics by various mitogens in cells ([@b34-etm-0-0-3003]).

A total of 36 miRNAs were screened including MIR-494, MIR-501, MIR-524 and MIR-142-3P. Furthermore, an miRNA regulatory network was constructed based on the DEGs and screened miRNAs. It was found that ATF3 was only regulated by MIR-494. Similarly, Lan *et al* found that following reperfusion, the expression of ATF3 was inhibited by upregulated miRNA-494, and also associated with inflammation and adhesion ([@b35-etm-0-0-3003]). In addition, there was mutual regulated relationship between EGR2 and MIR-142-3P: ERG2 was encoded by the genes repressed by MIR-142-3P, while ERG2 associated with nerve growth factor-induced gene-A (NGFI-A) binding protein 2 binds to the pre-MIR-142-3p promoter to regulate its expression negatively ([@b36-etm-0-0-3003]).

In conclusion, the identified DEGs, such as FOS, IL6, EGR2 and JUN, might participate in biological processes including immune inflammation responses, the Toll-like receptor signaling pathway and the defense response of patients following OPCAB surgery. Moreover, the associations between DEGs and miRNA were screened. ATF3 was regulated by MIR-494, and JUN was regulated by MIR-501 and MIR494. However, these results require confirmation by experimental study.

The authors express warm thanks to Fenghe (Shanghai) Information Technology Co., Ltd., whose ideas and help provided a valuable added dimension to the study.
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###### 

Top 10 differentially expressed genes (DEGs).

  DEG      Log2FC     P-value
  -------- ---------- ----------
  FOS      3.855915   0.000293
  CCL3     3.369698   1.05E-07
  CCL3L1   3.369698   1.05E-07
  CCL3L3   3.369698   1.05E-07
  EGR2     3.149878   9.33E-06
  NR4A2    3.015238   3.16E-05
  ZFP36    2.983598   2.55E-06
  FOSB     2.974505   0.000304
  EGR3     2.961837   4.57E-05
  CH25H    2.734594   0.000209

Log2FC is the logarithmic value of the DEG variation range. FOS, FBJ murine osteosarcoma viral oncogene homolog; CCL3, chemokine (C-C motif) ligand 3; CCL3L1, chemokine (C-C motif) ligand 3-like 1; CCL3L3, chemokine (C-C motif) ligand 3-like 3; EGR2, early growth response 2; NR4A2, nuclear receptor subfamily 4, group A, member 2; ZFP36, ZFP36 ring finger protein; FOSB, FBJ murine osteosarcoma viral oncogene homolog B; EGR3, early growth response 3; CH25H, cholesterol 25-hydroxylase.

###### 

Functional enrichment analysis for upregulated DEGs.

  Category   GO id        Description                                                            P-value^[a](#tfn2-etm-0-0-3003){ref-type="table-fn"}^   Genes
  ---------- ------------ ---------------------------------------------------------------------- ------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------
  BP         GO:0007610   Behavior                                                               1.57E-15                                                EGR1, IL6, CCL3, EGR2, CCL2, C5AR1, IL8, PTGS2, S100A9, CXCL2, NR4A2, CCL8, FOSB, NR4A3, CCL4, PROK2, FOS, CXCR4, CCL3L1, JUN, CCL3L3, CYR61
  BP         GO:0042330   Taxis                                                                  2.21E-12                                                CCL3, IL6, CCL2, C5AR1, IL8, CXCL2, S100A9, CCL8, CCL4, PROK2, CXCR4, CCL3L1, CCL3L3, CYR61
  BP         GO:0006935   Chemotaxis                                                             2.21E-12                                                CCL3, IL6, CCL2, C5AR1, IL8, CXCL2, S100A9, CCL8, CCL4, PROK2, CXCR4, CCL3L1, CCL3L3, CYR61
  BP         GO:0006954   Inflammatory response                                                  3.29E-12                                                NFKBIZ, IL6, CCL3, CCL2, IL8, S100A8, CXCL2, S100A9, CCL8, CCL4, S100A12, FOS, PROK2, CXCR4, CCL3L1, CCL3L3, SELE
  BP         GO:0007626   Locomotory behavior                                                    8.03E-11                                                CCL3, IL6, CCL2, C5AR1, IL8, CXCL2, S100A9, NR4A2, CCL8, CCL4, PROK2, CXCR4, CCL3L1, CCL3L3, CYR61
  BP         GO:0006952   Defense response                                                       3.10E-10                                                NFKBIZ, IL6, CCL3, CCL2, C5AR1, IL8, S100A8, CXCL2, S100A9, CCL8, CCL4, S100A12, CD83, PROK2, FOS, CXCR4, CCL3L1, CCL3L3, SELE
  BP         GO:0009611   Response to wounding                                                   3.11E-09                                                NFKBIZ, IL6, CCL3, CCL2, IL8, S100A8, CXCL2, S100A9, CCL8, CCL4, S100A12, FOS, PROK2, CXCR4, CCL3L1, CCL3L3, SELE
  BP         GO:0010033   Response to organic substance                                          3.51E-09                                                EGR1, IL6, EGR2, CCL2, PTGS2, SOCS3, NR4A2, NR4A3, PMAIP1, JUNB, CD83, FOS, DUSP1, BTG2, JUN, SELE, MYC, CYR61
  BP         GO:0045944   Positive regulation of transcription from RNA polymerase II promoter   3.39E-07                                                EGR1, FOS, IL6, EGR2, JUN, CSRNP1, NR4A2, ABRA, NR4A3, MYC, KLF4, JUNB
  BP         GO:0002237   Response to molecule of bacterial origin                               1.55E-06                                                FOS, IL6, CCL2, PTGS2, SOCS3, JUN, SELE
  MF         GO:0008009   Chemokine activity                                                     2.25E-08                                                CCL3, CCL2, IL8, CCL3L1, CXCL2, CCL3L3, CCL8, CCL4
  MF         GO:0042379   Chemokine receptor binding                                             3.34E-08                                                CCL3, CCL2, IL8, CCL3L1, CXCL2, CCL3L3, CCL8, CCL4
  MF         GO:0003700   Transcription factor activity                                          2.99E-06                                                EGR1, MAFF, EGR3, EGR2, CEBPD, NR4A2, NR4A3, FOSB, JUNB, FOS, ATF3, JUN, CSRNP1, BHLHE40, MYC, KLF4
  MF         GO:0005125   Cytokine activity                                                      1.02E-05                                                CCL3, IL6, CCL2, IL8, CCL3L1, CXCL2, CCL3L3, CCL8, CCL4
  MF         GO:0043565   Sequence-specific DNA binding                                          1.84E-05                                                EGR1, MAFF, FOS, ATF3, CEBPD, JUN, NR4A2, NR4A3, FOSB, MYC, KLF4, JUNB
  MF         GO:0030528   Transcription regulator activity                                       3.70E-05                                                EGR1, MAFF, EGR3, EGR2, CEBPD, NR4A2, NR4A3, FOSB, JUNB, FOS, ATF3, JUN, CSRNP1, ABRA, BHLHE40, SIK1, MYC, KLF4
  MF         GO:0003690   Double-stranded DNA binding                                            3.76E-05                                                EGR1, FOS, JUN, MYC, KLF4, JUNB
  MF         GO:0043566   Structure-specific DNA binding                                         2.52E-04                                                EGR1, FOS, JUN, MYC, KLF4, JUNB
  MF         GO:0003677   DNA binding                                                            0.002359                                                ZFP36, EGR1, MAFF, EGR3, EGR2, CEBPD, NR4A2, NR4A3, FOSB, ZNF331, JUNB, FOS, ATF3, JUN, CSRNP1, BHLHE40, SOX17, MYC, KLF4
  MF         GO:0008201   Heparin binding                                                        0.007664                                                CCL2, CCL8, ADAMTS1, CYR61

Enriched P-value based on the principle of hypergeometric distribution. DEGs, differently expressed genes; GO id, gene ontology identifier; BP, biological process; MF, molecular function.

###### 

Results of KEGG pathway enrichment analysis for upregulated DEGs.

  Term       Description                              P-value    Genes
  ---------- ---------------------------------------- ---------- ----------------------------------------------------------------
  hsa04062   Chemokine signaling pathway              2.23E-05   CCL3, CCL2, IL8, CXCR4, CCL3L1, CXCL2, CCL3L3, CCL8, CCL4
  hsa04060   Cytokine-cytokine receptor interaction   2.24E-05   CCL3, IL6, CCL2, IL8, CXCR4, CCL3L1, CXCL2, CCL3L3, CCL8, CCL4
  hsa04620   Toll-like receptor signaling pathway     1.08E-04   FOS, CCL3, IL6, IL8, JUN, CCL4
  hsa04621   NOD-like receptor signaling pathway      2.09E-04   IL6, CCL2, IL8, CXCL2, CCL8
  hsa04010   MAPK signaling pathway                   0.008586   DUSP5, FOS, DUSP1, JUN, GADD45B, MYC

KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; NOD, nucleotide-binding oligomerization domain; MAPK, mitogen-activated protein kinase.

###### 

Top 10 nodes in the protein-protein interaction network.

  Node   Degree   Log2FC     P-value    Node    Degree   Log2FC     P-value
  ------ -------- ---------- ---------- ------- -------- ---------- ----------
  FOS    33       3.855915   0.000293   JUNB    23       1.970841   8.05E-05
  JUN    25       1.174318   0.00015    PTGS2   19       1.582406   0.000342
  ATF3   25       1.655723   1.62E-05   EGR1    18       2.609822   3.79E-06
  IL6    24       1.942007   0.000494   EGR2    18       3.149878   9.33E-06
  FOSB   23       2.974505   0.000304   NR4A2   18       3.015238   3.16E-05

FC, fold change.

###### 

Significantly enriched miRNAs.

  Name^[a](#tfn5-etm-0-0-3003){ref-type="table-fn"}^                                                                                      Size^[b](#tfn6-etm-0-0-3003){ref-type="table-fn"}^   ES         NES        NOM P-value   FDR q-value
  --------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ---------- ---------- ------------- -------------
  GTGACTT, MIR-224                                                                                                                        152                                                  0.562058   1.822214   0             0.013101
  GTCTTCC, MIR-7                                                                                                                          163                                                  0.437548   1.825578   0             0.013673
  CAGGTCC, MIR-492                                                                                                                          59                                                 0.559375   1.757292   0             0.015391
  AGCGCTT, MIR-518F, MIR-518E, MIR-518A                                                                                                     18                                                 0.632514   1.786852   0.019417      0.015701
  CTGTTAC, MIR-194                                                                                                                        102                                                  0.514465   1.748545   0             0.015956
  ATTACAT, MIR-380-3P                                                                                                                     100                                                  0.568861   1.741315   0             0.01598
  CAGGGTC, MIR-504                                                                                                                          83                                                 0.447092   1.763647   0             0.016012
  CACTGCC, MIR-34A, MIR-34C, MIR-449                                                                                                      273                                                  0.327004   1.722042   0             0.017363
  GTAAACC, MIR-299--5P                                                                                                                      51                                                 0.518946   1.692057   0             0.018053
  ACACTAC, MIR-142--3P                                                                                                                    127                                                  0.5551     1.722499   0             0.018404
  TCTATGA, MIR-376A, MIR-376B                                                                                                               81                                                 0.461825   1.694669   0.007561      0.018496
  TTGGGAG, MIR-150                                                                                                                          89                                                 0.463794   1.681071   0             0.019215
  GGCACAT, MIR-455                                                                                                                          57                                                 0.545086   1.868148   0             0.019345
  GCGCCTT, MIR-525, MIR-524                                                                                                                 15                                                 0.735336   1.694803   0.020121      0.019371
  ACTGCCT, MIR-34B                                                                                                                        212                                                  0.400143   1.70374    0             0.019561
  GGCACTT, MIR-519E                                                                                                                       120                                                  0.49198    1.675179   0             0.020529
  AGGCACT, MIR-515--3P                                                                                                                      84                                                 0.428035   1.666043   0             0.021838
  GACTGTT, MIR-212, MIR-132                                                                                                               154                                                  0.457287   1.655331   0             0.022945
  TATTATA, MIR-374                                                                                                                        282                                                  0.49871    1.650721   0             0.023073
  CACCAGC, MIR-138                                                                                                                        217                                                  0.31838    1.645393   0             0.024967
  CTACCTC, LET-7A, LET-7B, LET-7C, LET-7D, LET-7E, LET-7F, MIR-98, LET-7G, LET-7I                                                         375                                                  0.358576   1.62671    0             0.03133
  GAGCCAG, MIR-149                                                                                                                        143                                                  0.30404    1.62081    0             0.031399
  CCACACA, MIR-147                                                                                                                          59                                                 0.485473   1.621963   0             0.032141
  ACTTTAT, MIR-142--5P                                                                                                                    283                                                  0.475001   1.606214   0             0.034741
  AAAGGAT, MIR-501                                                                                                                        125                                                  0.459692   1.600922   0             0.035487
  AGCACTT, MIR-93, MIR-302A, MIR-302B, MIR-302C, MIR-302D, MIR-372, MIR-373, MIR-520E, MIR-520A, MIR-526B, MIR-520B, MIR-520C, MIR-520D   330                                                  0.465894   1.606906   0.005814      0.035811
  CACTTTG, MIR-520G, MIR-520H                                                                                                             230                                                  0.487052   1.602      0.003876      0.036012
  CAATGCA, MIR-33                                                                                                                           91                                                 0.479179   1.607379   0             0.036792
  GTGCAAT, MIR-25, MIR-32, MIR-92, MIR-363, MIR-367                                                                                       304                                                  0.440998   1.581268   0             0.042634
  ATGTTTC, MIR-494                                                                                                                        155                                                  0.455721   1.578166   0.015717      0.043117
  GCAAAAA, MIR-129                                                                                                                        182                                                  0.431128   1.577369   0.031558      0.043279
  GACAATC, MIR-219                                                                                                                        138                                                  0.403393   1.574232   0             0.0444
  CTAGGAA, MIR-384                                                                                                                          64                                                 0.439962   1.566436   0             0.044528
  CACTGTG, MIR-128A, MIR-128B                                                                                                             327                                                  0.344783   1.567878   0.005941      0.045063
  TATCTGG, MIR-488                                                                                                                          60                                                 0.520626   1.568708   0             0.045787
  GGGCATT, MIR-365                                                                                                                        107                                                  0.509769   1.558457   0.003883      0.04858

Initial 7 bases are the target sites of the miRNA

size is the number of regulatory target genes. miRNA, microRNA; ES, enrichment score; NES, normalized enrichment score; NOM, normalized; FDR, false discovery rate (adjusted P-value).
